These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11695576)

  • 1. Society of toxicologic pathology position paper: diet as a variable in rodent toxicology and carcinogenicity studies.
    Nold JB; Keenan KP; Nyska A; Cartwright ME
    Toxicol Pathol; 2001; 29(5):585-6. PubMed ID: 11695576
    [No Abstract]   [Full Text] [Related]  

  • 2. Society of toxicologic pathology position on assessment of hyperplastic lesions in rodent carcinogenicity studies.
    Boorman G; Dixon D; Elwell M; Kerlin R; Morton D; Peters T; Regan K; Sullivan J;
    Toxicol Pathol; 2004; 32(1):124-5. PubMed ID: 14713557
    [No Abstract]   [Full Text] [Related]  

  • 3. Recommended tissue list for histopathologic examination in repeat-dose toxicity and carcinogenicity studies: a proposal of the Society of Toxicologic Pathology (STP).
    Bregman CL; Adler RR; Morton DG; Regan KS; Yano BL;
    Toxicol Pathol; 2003; 31(2):252-3. PubMed ID: 12696587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplement 1, Toxicologic Pathology, March/April 2004 should be must reading for all pathologists.
    Wagner BM
    Toxicol Pathol; 2004; 32(5):613. PubMed ID: 15603545
    [No Abstract]   [Full Text] [Related]  

  • 5. The Society of Toxicologic Pathology's position on statistical methods for rodent carcinogenicity studies.
    Morton D
    Toxicol Pathol; 2001; 29(6):670-2. PubMed ID: 11794383
    [No Abstract]   [Full Text] [Related]  

  • 6. Society of Toxicologic Pathology position on histopathology data collection and audit trail: compliance with 21 CFR parts 58 and 11.
    Tuomari D; Elliott G; Kulwich B; Yarrington J; Fouillet X; Geoly F; Long P
    Toxicol Pathol; 2004; 32(1):122-3. PubMed ID: 14713556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Best practices for reporting pathology interpretations within GLP toxicology studies.
    Morton D; Kemp RK; Francke-Carroll S; Jensen K; McCartney J; Monticello TM; Perry R; Pulido O; Roome N; Schafer K; Sellers R; Snyder PW
    Toxicol Pathol; 2006; 34(6):806-9. PubMed ID: 17162539
    [No Abstract]   [Full Text] [Related]  

  • 8. Society of Toxicologic Pathology position paper on pathology image data: compliance with 21 CFR Parts 58 and 11.
    Tuomari DL; Kemp RK; Sellers R; Yarrington JT; Geoly FJ; Fouillet XL; Dybdal N; Perry R;
    Toxicol Pathol; 2007 Apr; 35(3):450-5. PubMed ID: 17474067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory forum.
    Foster JR
    Toxicol Pathol; 2009 Apr; 37(3):269. PubMed ID: 19380838
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulatory forum opinion piece: the role of the toxicologic pathologist in the postgenomic era: challenges and opportunities.
    Maronpot RR
    Toxicol Pathol; 2012 Oct; 40(7):1082-6. PubMed ID: 22585943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Society of Toxicologic Pathology position paper on best practices on recovery studies: the role of the anatomic pathologist.
    Perry R; Farris G; Bienvenu JG; Dean C; Foley G; Mahrt C; Short B;
    Toxicol Pathol; 2013; 41(8):1159-69. PubMed ID: 23531793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Best practices guideline: toxicologic histopathology.
    Crissman JW; Goodman DG; Hildebrandt PK; Maronpot RR; Prater DA; Riley JH; Seaman WJ; Thake DC
    Toxicol Pathol; 2004; 32(1):126-31. PubMed ID: 14713558
    [No Abstract]   [Full Text] [Related]  

  • 13. STP debate on the desirability of an international mechanism for recognizing qualified toxicologic pathologists.
    Bolon B; Ochoa R; Mann P
    Toxicol Pathol; 2009 Dec; 37(7):992-6. PubMed ID: 19820139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory Forum.
    Peden WM
    Toxicol Pathol; 2016 Dec; 44(8):1069-1071. PubMed ID: 27753636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Best practices for use of historical control data of proliferative rodent lesions.
    Keenan C; Elmore S; Francke-Carroll S; Kemp R; Kerlin R; Peddada S; Pletcher J; Rinke M; Schmidt SP; Taylor I; Wolf DC
    Toxicol Pathol; 2009 Aug; 37(5):679-93. PubMed ID: 19454599
    [No Abstract]   [Full Text] [Related]  

  • 16. Global recognition of qualified toxicologic pathologists: where we are now and where we need to go.
    Ettlin RA; Bolon B; Pyrah I; Konishi Y; Black HE
    Toxicol Pathol; 2008 Jul; 36(5):753-9. PubMed ID: 18648095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global recognition of qualified toxicologic pathologists: where we are now and where we need to go.
    Ettlin RA; Bolon B; Pyrah I; Konishi Y; Black HE
    Exp Toxicol Pathol; 2008 Jun; 60(1):1-8. PubMed ID: 18424010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology and tissue sampling protocols for rodent carcinogenicity studies: time for revision.
    Leblanc B
    Toxicol Pathol; 2000; 28(4):628-33. PubMed ID: 10930051
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulatory forum opinion piece: Peer review documentation and pathology data locking.
    Neef N
    Toxicol Pathol; 2014; 42(2):311-3. PubMed ID: 24357644
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulatory forum opinion piece*: pathology peer review--dilemmas of documentation.
    Kerlin RL; Schafer KA
    Toxicol Pathol; 2013; 41(7):1049-50. PubMed ID: 23960162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.